Literature DB >> 17143118

Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis.

Antonio Pelliccia1, Domenico Corrado, Hans Halvor Bjørnstad, Nicole Panhuyzen-Goedkoop, Axel Urhausen, Francois Carre, Aris Anastasakis, Luc Vanhees, Eloisa Arbustini, Silvia Priori.   

Abstract

Several relatively uncommon, but important cardiovascular diseases are associated with increased risk for acute cardiac events during exercise (including sudden death), such as hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC) and myo-pericarditis. Practising cardiologists are frequently asked to advise on exercise programmes and sport participation in young individuals with these cardiovascular diseases. Indeed, many asymptomatic (or mildly symptomatic) patients with cardiomyopathies aspire to a physically active lifestyle to take advantage of the many documented benefits of exercise. While recommendations dictating the participation in competitive sport for athletes with cardiomyopathies and myo-pericarditis have recently been published as a consensus document of the European Society of Cardiology, no European guidelines have addressed the possible participation of patients with cardiomyopathies in recreational and amateur sport activities. The present document is intended to offer a comprehensive overview to practising cardiologists and sport physicians of the recommendations governing safe participation in different types of competitive sport, as well as the participation in a variety of recreational physical activities and amateur sports in individuals with cardiomyopathies and myo-pericarditis. These recommendations, based largely on the experience and insights of the expert panel appointed by the European Society of Cardiology, include the most up-to-date information concerning regular exercise and sports activity in patients with cardiomyopathies and myo-pericarditis.

Entities:  

Mesh:

Year:  2006        PMID: 17143118     DOI: 10.1097/01.hjr.0000238393.96975.32

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  35 in total

1.  Exercise in hypertrophic cardiomyopathy.

Authors:  Sharlene M Day
Journal:  J Cardiovasc Transl Res       Date:  2009-10-14       Impact factor: 4.132

Review 2.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

3.  Arrhythmogenic right ventricular cardiomyopathy (ARVC): case report and review of literature.

Authors:  Usha Rao; S Agarwal; T J Gilbert
Journal:  Heart Asia       Date:  2014-10-01

4.  Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Anne-Christine Ruwald; Frank Marcus; N A Mark Estes; Mark Link; Scott McNitt; Bronislava Polonsky; Hugh Calkins; Jeffrey A Towbin; Arthur J Moss; Wojciech Zareba
Journal:  Eur Heart J       Date:  2015-04-20       Impact factor: 29.983

Review 5.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.

Authors:  A Azaouagh; S Churzidse; T Konorza; R Erbel
Journal:  Clin Res Cardiol       Date:  2011-03-01       Impact factor: 5.460

Review 6.  Prevalence and spectrum diseases predisposing to sudden cardiac death: are they the same for both the athlete and the nonathlete?

Authors:  Anjan S Batra; Seshadri Balaji
Journal:  Pediatr Cardiol       Date:  2012-03       Impact factor: 1.655

7.  Acute and recurring pericarditis: More colchicine, less corticosteroids.

Authors:  Paul Farand; Francis Bonenfant; Emilie P Belley-Côté; Nicholas Tzouannis
Journal:  World J Cardiol       Date:  2010-12-26

Review 8.  The Impending Dilemma of Electrocardiogram Screening in Athletic Children.

Authors:  Laure Léger; Boris Gojanovic; Nicole Sekarski; Erik J Meijboom; Yvan Mivelaz
Journal:  Pediatr Cardiol       Date:  2015-08-20       Impact factor: 1.655

Review 9.  [Myocarditis and sudden cardiac death in athletes. Diagnosis, treatment, and prevention].

Authors:  Matthias Frick; Otmar Pachinger; Gerhard Pölzl
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

Review 10.  Hypertrophic cardiomyopathy as a cause of sudden death.

Authors:  Hubert Seggewiss; Christoph Blank; Barbara Pfeiffer; Angelos Rigopoulos
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.